Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ian Sanne, MBBCH, FCP
University of the Witwatersrand. Themba Lethu Clinic.
Principal Investigator - Irini Sereti, M.D., MHS
National Institute of Allergy and Infectious Diseases (NIAID)
Principal Investigator - Juan G Sierra Madero, MD
Insituto Nacional de Nutricion de Ciencias Medicas y Nutricion Salvador Zubiran
Principal Investigator - Livio Azzoni, MD, PhD
HIV-1 Immunopathogenesis Laboratory. The Wistar Institute
Principal Investigator - Luis J Montaner, M.Sc.
HIV-1 Immunopathogenesis Laboratory. The Wistar Institute
Principal Investigator - Michael M. Lederman, MD
Center for AIDS Research. Case Western Reserve University
Principal Investigator - Susan Ellenberg, Ph.D.
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital General de León
León, Guanajuato, Mexico
- Hospital Civil de Guadalajara
Guadalajara, Jalisco, Mexico
- Hospital General de México
Mexico City, Mexico City, Mexico
- Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán
Mexico City, Mexico City, Mexico
- Hospital Central Dr. Ignacio Morones Prieto
San Luis Potosí City, San Luis Potosí, Mexico
- Clinical Hiv Research Unit. Themba Lethu Clinic. Helen Joseph Hospital
Johannesburg, Gauteng, South Africa
- Nih/niad
Bethesda, Maryland, United States
- Center for Aids Research. Case Western Reserve University
Cleveland, Ohio, United States
- Center for Clinical Epidemiology and Biostatistics. University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania, United States
- Hiv-1 Immunopathogenesis Laboratory. the Wistar Institute
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2009
- Primary completion
- 31 Mar 2013
- Completion
- 30 Apr 2013
- Last update posted
- 27 Nov 2012
- Registered enrollment
- 276
- Registry id
- NCT00988780
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.